key: cord-1054430-bpqj1mbl
authors: Hornick, Andrew; Tashtish, Nour; Osnard, Michael; Shah, Binita; Bradigan, Allison; Albar, Zainab; Tomalka, Jeffrey; Dalton, Jarrod; Sharma, Ashish; Sekaly, Rafick P.; Hejal, Rana; Simon, Daniel I.; Zidar, David A.; Al-Kindi, Sadeer G.
title: Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults
date: 2020-10-02
journal: Pathog Immun
DOI: 10.20411/pai.v5i1.391
sha: 741b3002e2398e0d088279b6d8afd91830ff08b3
doc_id: 1054430
cord_uid: bpqj1mbl

BACKGROUND: Red cell distribution width (RDW), a measure of anisocytosis, is observed in chronic inflammation and is a prognostic marker in critically ill patients without COVID-19, but data in COVID-19 are limited. METHODS: Between March 12 and April 19, 2020, 282 individuals with confirmed COVID-19 and RDW available within 7 days prior to COVID-19 confirmation were evaluated. Individuals were grouped by quartiles of RDW. Association between quartiles of RDW and mortality was assessed using the Kaplan-Meier method and statistical significance was assessed using the log-rank test. The association between RDW and all-cause mortality was further assessed using a Cox proportional hazards model. Plasma cytokine levels in uninfected ambulatory adults without cardiovascular disease (n=38) were measured and bivariate Spearman correlations and principle components analysis were used to identify relationships between cytokine concentrations with RDW. RESULTS: After adjusting for age, sex, race, cardiovascular disease, and hemoglobin, there was an association between RDW and mortality (Quartile 4 vs Quartile 1: HR 4.04 [1.08-15.07]), with each 1% increment in RDW associated with a 39% increased rate of mortality (HR 1.39 [1.21-1.59]). Remote RDW was also associated with mortality after COVID-19 infection. Among uninfected ambulatory adults without cardiovascular disease, RDW was associated with elevated pro-inflammatory cytokines (TNF-α, IL8, IL6, IL1b), but not regulatory cytokines (TGFb). CONCLUSIONS: Anisocytosis predicts short-term mortality in COVID-19 patients, often predates viral exposure, and may be related to a pro-inflammatory phenotype. Additional study of whether the RDW can assist in the early identification of pending cytokine storm is warranted.

The coronavirus disease 2019 (COVID- 19) pandemic rapidly rose to prominence in the United States during the first months of 2020. Numerous studies have sought to identify both the mechanism of severe disease and prognostic methods to identify patients at risk for progression to severe disease and death. Reported data consistently identify dysregulation of inflammatory and thrombotic pathways in patients with severe COVID-19 [1] [2] [3] [4] . Studies of the host response reveal a complex immunopathogenesis with failure of type 1 interferon responses [5] , hyper-inflammation [6] , T cell exhaustion [7] , and ineffective adaptive/antibody responses [8] in those with a progressive course. There is a need to develop biomarkers to identify patients at increased risk for the development of a severe clinical COVID-19 course for whom preventive strategies can be targeted.

Red blood cell distribution width (RDW), a measure of the variability of circulating erythrocyte size, is routinely reported as part of a complete blood count, but is not typically used clinically. Elevated RDW is associated with poor outcomes in a wide variety of disease states, including cardiovascular disease, stroke, and critical illness [9] [10] [11] [12] . RDW has also been shown to correlate with measures of inflammation in non-COVID-19 settings, including tumor necrosis factor (TN-F)-α [13] in sepsis, interleukin (IL)-6 [14, 15] in heart failure and human immunodeficiency virus infection, and high sensitivity C-Reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR) [16, 17] in other populations.

The primary aim of this study was to determine whether RDW, assessed prior to infection, was associated with short-term mortality among patients with confirmed COVID-19 in a single large integrated academic health system. We additionally performed an analysis of an uninfected ambulatory cohort to understand the inflammatory correlates of RDW.

In this retrospective study, we studied consecutive patients who tested positive for COVID-19 using a viral polymerase chain reaction (PCR) test between March 12 and April 19, 2020 at University Hospitals Health System. University Hospitals Health System is comprised of 14 hospitals serving over 1 million patients in northeast Ohio. Inclusion criteria included positive COVID-19 PCR test and available RDW within 7 days prior to COVID-19 PCR test. Patients <18 years were excluded. We extracted demographics, medical history (diabetes, hypertension, lung disease, cardiovascular disease, and cancer) and laboratory markers from within 7 days prior to COVID-19 confirmation (leukocyte count, neutrophil count, monocyte count, lymphocyte count, hemoglo-bin, mean corpuscular volume [MCV] , RDW, and platelet count) from the automatically queried electronic medical records. All labs were performed at local clinical facilities and reported in the system-wide electronic medical record system. The primary outcome was defined as all-cause mortality, which was ascertained through review of medical records and linkage with State of Ohio death index files.

The baseline demographics and characteristics of participants grouped by RDW quartiles were compiled as raw numbers and percentages for categorical variables and means and standard deviation for continuous variables. Statistical significance was examined using chi-square and analysis of variance F-tests (overall comparisons) and by trend tests (Mantel-Haenszel test for categorical variables and Spearman rank test for continuous variables). A Wilcoxon paired test was used to compare remote RDW, defined as a value from >7 days prior to testing positive for COVID-19, and acute RDW, defined as a value from <7 days prior to testing positive for COVID-19. The association between RDW and mortality was further investigated using RDW as a continuous variable and penalized smoothed spline with Cox proportional hazards regression models. Association between quartiles of RDW and mortality was assessed using the Kaplan-Meier method and statistical significance was assessed using the log-rank test. To evaluate the association between RDW quartiles and mortality, we constructed three Cox proportional hazard models with increasing adjustment. There is an unadjusted model, as well as a model (model 1) adjusted for age, sex, and race. The second model (model 2) was additionally adjusted for hemoglobin and preexisting cardiovascular disease. To analyze the predictive power of RDW, we performed time-sensitive receiver operating characteristics at 30 days using "survivalROC" function in RStudio. ROC analysis for 30-day mortality was also performed for age as a comparator. Cut-points were identified with 80% sensitivity and 80% specificity. Optimal cut-point was identified using maximal Youden index (highest sensitivity+specificity).

Given the results of the primary analysis described above, we conducted a post-hoc study of cytokines in ambulatory volunteers without a history of cardiovascular disease to generate hypotheses of the mechanism of action on which RDW is reflective. Inclusion criteria for participation in the study included ≥18 years with no history of atherosclerotic cardiovascular disease. To determine the cytokines that relate to RDW, we measured 23 plasma cytokines in uninfected ambulatory adults (n=38) using electrochemiluminescence (Meso Scale Discovery, Gaithersburg, Maryland, USA). Twenty-two of these cytokines gave non-zero levels and were analyzed using Spearman correlations, hierarchical clustering, and principal component analyses. All analyses were performed in Statistical Package for Social Sciences (SPSS, version 23, IBM, NY) and RStudio version 1.2.1335 (R project, Austria). Informed consent was obtained from all human subject study participants, and University Hospitals' Institutional Review Board reviewed and provided approval for the study protocol.

A total of 282 patients were included. Median [quartiles] age was 63 [53-75] years; 137 (49%) were male and 173 (61.3%) were white. The majority of patients were hospitalized (n=175, 62%), 74 (26%) were discharged from the emergency department, and the remaining patients (n=33, 12%) were diagnosed and managed as outpatients. Demographics and baseline characteristics are shown by RDW quartile. At a median follow-up of 20 [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] days, 39 patients died (2 were initially managed in an ambulatory setting, 2 were initially managed in the emergency department, and 35 were hospitalized), with a cumulative mortality rate of 22%. Mortality rate was 6.9% in RDW quartile 1, 11.0% in RDW quartile 2, 13.2% in RDW quartile 3, and 53.6% in RDW quartile 4. Figure 1A shows When RDW was treated as a continuous variable, there was a semi-linear association between RDW and hazard of mortality ( figure 1B) . The relationship between RDW and hazards of mortality by age group is shown in figure 1C . This figure suggests that there is a continued relationship between RDW and mortality in all age groups, and that a 1% increase in RDW confers a similar mortality effect to a 10-year increase in age. There was no interaction between RDW and age (P interaction =0.83), further suggesting a uniform association between RDW and mortality across the age spectrum. RDW, as a standalone marker, had good predictive power for short-term mortality with an area under the receiver operating characteristics curve (ROC AUC) of 0.81. The ROC curve is shown in figure 1D . RDW of 13.6% had 80% sensitivity and 59% specificity to predict mortality, while RDW of 14.5% (optimal cut-point) had 72% sensitivity and 81% specificity to predict 30-day mortality. As a comparator, age had a lower AUC of 0.75. Age of 63 years had 80% sensitivity and 58% specificity to predict 30-day mortality, while age of 74 years had 50% sensitivity and 80% specificity to predict 30-day mortality. Age 67 years was the optimal cut-off point, with a sensitivity of 77% and specificity of 68%. Figure 3B shows the Kaplan-Meier survival curves by quartile of remote RDW.

Among the uninfected ambulatory cohort (n=38, with mean age of 56.6 ± 6.6 years, 17 females, 37 Caucasians, 21 with dyslipidemia, 9 with hypertension, 3 smokers, 0 with diabetes, 0 with 

Our data demonstrate several novel observations. We find that those with anisocytosis (elevated RDW) are at risk for short-term mortality due to COVID-19. This relationship is independent of clinical risk factors, including cardiovascular disease. Furthermore, anisocytosis (and its associated risk) appears to predate COVID-19 because the RDW at the time of diagnosis was similar to patients' most recent pre-infection values. We also find that, in uninfected ambulatory adults without cardiovascular disease or COVID-19, an elevated RDW is associated with an altered cytokine milieu consisting of heightened pro-inflammatory cytokines, but without alterations in basal levels of type 1 interferons or homeostatic/regulatory cytokines. Thus, we conclude that, in the context of COVID-19, RDW may identify patients at heightened risk for progression to cytokine storm, and this may be due to a preexisting predilection for inflammation.

There is increasing evidence that patients with severe COVID-19 have greater inflammation. In a study of 21 patients with confirmed COVID-19 infection from Wuhan, China, severe cases (n=11) had higher levels of CRP, IL-2R, IL-6, IL-10, and TNF-α than moderate cases (n=10). Additionally, T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all patients, but were markedly lower in severe cases than in moderate cases. The expression of IFN-γ by CD4+ T cells was also lower in severe versus moderate cases [4] . However, the extent to which cytokine elevations are cause or consequence of a failing host response will require extensive mechanistic investigation, including the results of ongoing interventional trials. Our results add to the list of laboratory abnormalities that can be considered in the triage of patients, or when considering a patient's candidacy for advanced therapies. However, RDW demonstrated good discrimination and is a highly pragmatic test, widely available during routine care at little cost.

To our knowledge, no published study has identified RDW as a marker of mortality in COVID-19 infection. A prior study of patients from Wuhan, China using machine learning approaches identified RDW as a potential marker to identify severe COVID-19 infection [18] . A smaller nonpeer-reviewed preprint of a study of 45 Chinese patients with COVID-19 showed that RDW and neutrophil to lymphocyte ratio can discriminate between moderate and severe disease [19] .

Previous studies have reported that elevated RDW is associated with mortality in patients with critical illness and a variety of other disease states, including cardiovascular and cerebrovascular disease [9, 12, 20] . Our group recently showed that the risk of RDW extends to the general healthy population as well [21] . In a study of 31,178 ambulatory individuals from the National Health and Nutrition Examination Survey (1999-2010) that was followed for 12 years, RDW and ALC were independently associated with mortality, suggesting that putative CBC markers can be associated with risk of mortality. To our knowledge, this is the first report of RDW linkage with COVID-19 mortality.

Several groups, including our own, have previously demonstrated a correlation between RDW and IL-6 levels, as well as TNF-α in one report [9, 12, 15, 17] . This may be plausible, because IL-6 can induce hepcidin expression and TNF-α has been linked to erythropoietin resistance [12, 22] . Syndromes of acutely dysregulated inflammation, such as sepsis, are often accompanied by suppression of erythrocyte maturation [23] . We also studied a cohort of patients with chronic HIV infection wherein RDW retained its association with cardiovascular disease risk. In this cohort of virally-suppressed HIV-infected patients, RDW also correlated with IL-6, CD4+38+DR+T cells, and CD4+PD1+T cells [14] . A potential relationship with checkpoint molecule expression was independently corroborated in another study of 158 patients with HIV enrolled in the Hawaii Aging with HIV-Cardiovascular study, where authors demonstrated that RDW was associated with higher frequencies of CD38+HLA-DR+T cells, single TIGIT+, and dual expressing of TIG-IT+PD1+, TIGIT+TIM3+, and TIM3+PD1+CD8+ T-cell subsets [24] . Thus, the relationship between RDW and immune dysregulation is undoubtedly complex, and deserves closer scrutiny in follow-up studies. However, our current study adds to this literature in that we find that relationships between RDW and pro-inflammatory factors may precede illness onset. Interestingly, in this study we show that RDW does not significantly change with acute presentation of COVID-19 infection, suggesting that it may act as a pro-inflammatory signature that increases the individual's vulnerability to COVID-19-related adverse events. As RDW is commonly reported and there is a readily available test, it has unique utility in identifying patients at high risk for progression of COVID-19 to severe disease and death. These patients can be targeted with prevention strategies, post-exposure prophylaxis, vaccinations, and early interventions to reduce mortality.

This study is limited by its retrospective study design and relatively small sample size. There may be a bias toward ordering a complete blood count in patients who are sicker, a factor which is reflected by the high percentage of patients managed in the hospital setting (ED or inpatient). We lack data on iron studies, sickle cell anemia, and other factors that may have confounded the correlation with mortality. Therefore, findings need further validation before wide adoption in clinical practice.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Hlh Across Speciality Collaboration UK. COVID-19: consider cytokine storm syndromes and immunosuppression

SARS-CoV-2: a storm is raging

Clinical and immunological features of severe and moderate coronavirus disease 2019

Type 1 interferons as a potential treatment against COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

The many faces of the anti-COVID immune response

Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank

Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection

Prognostic Value of Red Blood Cell Distribution Width in Non-Cardiovascular Critically or Acutely Patients: A Systematic Review

Red cell distribution width and all-cause mortality in critically ill patients

Red blood cell distribution width during the first week is associated with severity and mortality in septic patients

Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV

Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure

Determining the Association between RDW and Traditional Markers of Inflammation

Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients

A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China

Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

Red cell distribution width and mortality in older adults: a meta-analysis

Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population

Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy

Red blood cell physiology in critical illness

Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adults